Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)

Phase 4 Unknown 23 enrolled Seattle Urology Research Center

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate that solifenacin post-operatively improves irritative symptoms in men whose obstructive symptoms have been relieved with the GreenLight laser outpatient procedure.

Timeline

Start: 2007-01
Primary completion: 2009-12
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Solifenacin	Small molecule	5 mg	Oral

Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)

Summary

Timeline

Drugs

Indications